Psychotropic drugs--those intended to change moods, numb anxiety, calm children--are pervasive in American culture. References are everywhere: not just in print and electronic advertisements but in television show dialogue, movies, song lyrics, and on advertising paraphernalia like notepads, wall clocks, mouse pads, coffee mugs, pens and pencils. The authors in this compilation of essays on psychotropic drugs and mass culture contend that society has been transformed into an asylum without walls--a "psychotropia." With each new definition of a mental ailment, a new cure is offered, increasing the number of inmates in this borderless asylum and blurring the lines between mental health and mental illness. Eight essays probe this issue, with an introduction and conclusion by the editor. The introduction frames the topic in the dehumanized asylums brought to light in 1961 by sociologist Erving Goffman, and in author Marshall McLuhan's warning not to be seduced by the media. Essay topics cover: how psychotropia came to be; drug portrayal in Hollywood; advertising in cyberspace and the postmodern condition; the advertising madness that promotes better living through chemistry; food as medicine; the music culture of psychotropia; children and psychotropic drugs; and stereotypes and manipulation in mass marketing. Instructors considering this book for use in a course may request an examination copy here.

Miller takes readers on an eye-opening tour of psychotropic drugs, describing the various kinds, how they were discovered and developed, and how they have played multiple roles in virtually every culture.

Whether in movies, cartoons, commercials, or even fast food marketing, psychology and mental illness remain pervasive in popular culture. In this collection of new essays, scholars from a range of fields explore representations of mental illness and disabilities across various media of popular culture. Contributors address how forms of psychiatric disorder have been addressed in film, on stage, and in literature, how popular culture genres are utilized to communicate often confusing and conflicted relationships with the mentally ill, and how popular cultures around the world reflect mental illness and disability. Analyses of sources as disparate as the Batman films, Broadway musicals and Nigerian home movies reveal how definitions of mental illness, mental health, and of psychology itself intersect with discourses on race, gender, law, capitalism, and globalization. Instructors considering this book for use in a course may request an examination copy here.

Pills replaced the couch; neuroscience took the place of talk therapy; and as psychoanalysis faded from the scene, so did the castrating mothers and hysteric spinsters of Freudian theory. Or so the story goes. In Prozac on the Couch, psychiatrist Jonathan Michel Metzl boldly challenges recent psychiatric history, showing that there’s a lot of Dr. Freud encapsulated in late-twentieth-century psychotropic medications. Providing a cultural history of treatments for depression, anxiety, and other mental illnesses through a look at the professional and popular reception of three “wonder drugs”—Miltown, Valium, and Prozac—Metzl explains the surprising ways Freudian gender categories and popular gender roles have shaped understandings of these drugs. Prozac on the Couch traces the notion of “pills for everyday worries” from the 1950s to the early twenty-first century, through psychiatric and medical journals, popular magazine articles, pharmaceutical advertisements, and popular autobiographical "Prozac narratives.” Metzl shows how clinical and popular talk about these medications often reproduces all the cultural and social baggage associated with psychoanalytic paradigms—whether in a 1956 Cosmopolitan article about research into tranquilizers to “cure” frigid women; a 1970s American Journal of Psychiatry ad introducing Jan, a lesbian who “needs” Valium to find a man; or Peter Kramer’s description of how his patient “Mrs. Prozac” meets her husband after beginning treatment. Prozac on the Couch locates the origins of psychiatry’s “biological revolution” not in the Valiumania of the 1970s but in American popular culture of the 1950s. It was in the 1950s, Metzl points out, that traditional psychoanalysis had the most sway over the American imagination. As the number of Miltown prescriptions soared (reaching 35 million, or nearly one per second, in 1957), advertisements featuring uncertain brides and unfaithful wives miraculously cured by the “new” psychiatric medicines filled popular magazines. Metzl writes without nostalgia for the bygone days of Freudian psychoanalysis and without contempt for psychotropic drugs, which he himself regularly prescribes to his patients. What he urges is an increased self-awareness within the psychiatric community of the ways that Freudian ideas about gender are entangled in Prozac and each new generation of wonder drugs. He encourages, too, an understanding of how ideas about psychotropic medications have suffused popular culture and profoundly altered the relationship between doctors and patients.

"Being crazy" is generally a negative characterization today, yet many celebrated artists, leaders, and successful individuals have achieved greatness despite suffering from mental illness. This book explores the many different representations of mental illness that exist—and sometimes persist—in both traditional and new media across eras. Mental health professionals and advocates typically point a finger at pop culture for sensationalizing and stigmatizing mental illness, perpetuating stereotypes, and capitalizing on the increased anxiety that invariably follows mass shootings at schools, military bases, or workplaces; on public transportation; or at large public gatherings. While drugs or street gangs were once most often blamed for public violence, the upswing of psychotic perpetrators casts a harsher light on mental illness and commands media's attention. What aspects of popular culture could play a role in mental health across the nation? How accurate and influential are the various media representations of mental illness? Or are there unsung positive portrayals of mental illness? This standout work on the intersections of pop culture and mental illness brings informed perspectives and necessary context to the myriad topics within these important, timely, and controversial issues. Divided into five sections, the book covers movies; television; popular literature, encompassing novels, poetry, and memoirs; the visual arts, such as fine art, video games, comics, and graphic novels; and popular music, addressing lyrics and musicians' lives. Some of the essays reference multiple media, such as a filmic adaptation of a memoir or a video game adaptation of a story or characters that were originally in comics. With roughly 20 percent of U.S. citizens taking psychotropic prescriptions or carrying a psychiatric diagnosis, this timely topic is relevant to far more individuals than many people would admit.

The explosive story of the discovery and development of psychiatric medications, as well as the science and the people behind their invention, told by a riveting writer and psychologist who shares her own experience with the highs and lows of psychiatric drugs. Although one in five Americans now takes at least one psychotropic drug, the fact remains that nearly seventy years after doctors first began prescribing them, not even their creators understand exactly how or why these drugs work -- or don't work -- on what ails our brains. Lauren Slater's revelatory account charts psychiatry's journey from its earliest drugs, Thorazine and lithium, up through Prozac and other major antidepressants of the present. Blue Dreams also chronicles experimental treatments involving Ecstasy, magic mushrooms, the most cutting-edge memory drugs, placebos, and even neural implants. In her thorough analysis of each treatment, Slater asks three fundamental questions: how was the drug born, how does it work (or fail to work), and what does it reveal about the ailments it is meant to treat? Fearlessly weaving her own intimate experiences into comprehensive and wide-ranging research, Slater narrates a personal history of psychiatry itself. In the process, her powerful and groundbreaking exploration casts modern psychiatry's ubiquitous wonder drugs in a new light, revealing their ability to heal us or hurt us, and proving an indispensable resource not only for those with a psychotropic prescription but for anyone who hopes to understand the limits of what we know about the human brain and the possibilities for future treatments.

With a Foreword by Danny Fingeroth, former Group Editor of Marvel's Spider-Man comics line Popular culture, simply stated, is the language of a people, expressed through everything from its clothing, food choices, and religious practices to its media. The popular and predominant values, interests, and needs of a society find their way into mass consciousness through a variety of venues including literature, cinema, television, video games, sport, and music. Through the inter-related forces of mass production, global marketing and the Internet, the fruits of popular culture penetrate into stores, living rooms, and everyday experience of children, teens, and adults in the form of catchphrases, toys, iconography, celebrities, and indelible images. Psychotherapists and counselors who can tap into the powerful images, messages, and icons of popular culture have at their disposal an unlimited universe of resources for growth, change, and healing. Using real-world case examples and sound psychological theory, this book demonstrates how you can immediately start incorporating popular culture icons and images into your counseling or therapy. In this way, the authors will help elevate your ability to conduct clinical interviews with clients of all ages and all types of clinical problems.

Valium. Paxil. Prozac. Prescribed by the millions each year, these medications have been hailed as wonder drugs and vilified as numbing and addictive crutches. Where did this “blockbuster drug” phenomenon come from? What factors led to the mass acceptance of tranquilizers and antidepressants? And how has their widespread use affected American culture? David Herzberg addresses these questions by tracing the rise of psychiatric medicines, from Miltown in the 1950s to Valium in the 1970s to Prozac in the 1990s. The result is more than a story of doctors and patients. From bare-knuckled marketing campaigns to political activism by feminists and antidrug warriors, the fate of psychopharmacology has been intimately wrapped up in the broader currents of modern American history. Beginning with the emergence of a medical marketplace for psychoactive drugs in the postwar consumer culture, Herzberg traces how “happy pills” became embroiled in Cold War gender battles and the explosive politics of the “war against drugs”—and how feminists brought the two issues together in a dramatic campaign against Valium addiction in the 1970s. A final look at antidepressants shows that even the Prozac phenomenon owed as much to commerce and culture as to scientific wizardry. With a barrage of “ask your doctor about” advertisements competing for attention with shocking news of drug company malfeasance, Happy Pills is an invaluable look at how the commercialization of medicine has transformed American culture since the end of World War II.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

"This book takes an integrative approach to the understanding of drug use and its relationship to social-cultural factors. It is lucidly and powerfully argued and constitutes a significant achievement. The authors sensibly argue that in order to fully understand and explain drug use and abuse it is necessary to take into account different levels of analysis, reflecting distinct domains of human functioning; the biological, psychosocial, and cultural-historical....Overall, this book represents an exceptional achievement and should be of interest to drug clinicians and researcher as well as social scientists and students." --Professor Tony Ward, University of Melbourne Substance use and abuse are two of the most frequent psychological problems clinicians encounter. Mainstream approaches focus on the biological and psychological factors supporting drug abuse. But to fully comprehend the issue, clinicians need to consider the social, historical, and cultural factors responsible for drug-related problems. Substance Use and Abuse: Cultural and Historical Perspectives provides an inclusive explanation of the human desire to take drugs. Using a multidisciplinary framework, authors Russil Durrant and Jo Thakker explore the cultural and historical variables that contribute to drug use. Integrating biological, psychosocial, and cultural-historical perspectives, this innovative and accessible volume addresses the fundamental question of why drug use is such a ubiquitous feature of human society. provides an inclusive explanation of the human desire to take drugs. Using a multidisciplinary framework, authors Russil Durrant and Jo Thakker explore the cultural and historical variables that contribute to drug use. Integrating biological, psychosocial, and cultural-historical perspectives, this innovative and accessible volume addresses the fundamental question of why drug use is such a ubiquitous feature of human society. Addressing issues important to prevention, treatment, and public policy, the authors include A comprehensive, historical survey of drug use An exploration of the evolutionary basis of drug-taking behavior Historically and culturally based explanations of drug use and abuse Inclusive approaches that complement mainstream biopsychosocial perspectives Designed for upper-division undergraduate and graduate students in psychology, counseling, sociology, social work, and health departments, Substance Use and Abuse: Cultural and Historical Perspectives will also be of significant interest to drug clinicians, researchers, and social scientists.